A team of investigators in the Massachusetts General Hospital.

Circulating tumor cells can show genetic signature of harmful lung cancers Using a miniature laboratory-on-a-chip gadget, a team of investigators in the Massachusetts General Hospital, led by Daniel Haber, M.D www.cabergoline05mg.com/restoring-normal-male-orgasms.html ., Ph.D., and Mehmet Toner, Ph.D., both known members of the MIT-Harvard Center for Cancers Nanotechnology Excellence , has developed a way that analyzes and detects the genetic signature of rare tumor cells in the bloodstream. The results out of this analysis allowed the researchers to recognize those patients most likely to respond to a particular targeted treatment. This chip-based analysis also allowed the experts to monitor genetic changes that take place during therapy.